Immunometabolism and Immunity

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".

Deadline for manuscript submissions: closed (31 December 2021) | Viewed by 5415

Special Issue Editors


E-Mail Website
Guest Editor
CSIC - Instituto de Investigaciones Marinas (IIM), Vigo, Spain
Interests: ambiental toxicology; immunology; molecular; cellular biology; flow cytometry; PCR; immunochemistry

E-Mail Website
Guest Editor
CSIC - Instituto de Investigaciones Marinas (IIM), Vigo, Spain
Interests: metabolism; metabolism disease; animal physiology; insulin resistance; nutrition

Special Issue Information

Dear Colleagues,

Research in immunometabolism is attracting growing interest. Immunometabolism is a cornerstone in adaptative and innate immune regulation, which plays a main role in immune cell reprogramming. Immunometabolism studies have revealed that some metabolites can act as immunomodulators, affecting the six main routes (glycolysis, tricarboxylic acid (TCA) cycle, pentose phosphate pathway, fatty acid oxidation, fatty acid synthesis, and metabolic amino acids) involved in immune cells reprogramming. Some metabolites participate in diverse biological processes, including modulation of vascular resistance, cell growth, survival, and stress, cell membrane structure, and immune responses. As a consequence, they have a powerful impact on health. Immune cell reprogramming is essential to maintain the pro-inflammatory/anti-inflammatory balance and, therefore, homeostasis, according to an organism’s requirements. Immune cell metabolism is remarkably plastic. The loss of this plastic behavior is reflected in specific chronic diseases. Immunostimulation and nutritional approaches could represent an alternative way to ensure optimal health; therefore, the modulation of the level and composition of metabolites could impact the immune system. The main goal of this Special Issue is to present immunometabolism and therapeutic immunometabolites as strategies to approach the treatment of diseases such as cancer, autoimmune disorders, and metabolic dysfunctions.

Dr. Marta Sendra
Dr. Marta Librán
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • immunometabolism
  • immunometabolites
  • immune cell reprogramming
  • inflammation
  • metabolic diseases

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

18 pages, 1265 KiB  
Review
Immunometabolism Modulation in Therapy
by Ezequiel Monferrer, Sabina Sanegre, Isaac Vieco-Martí, Amparo López-Carrasco, Fernando Fariñas, Antonio Villatoro, Sergio Abanades, Santos Mañes, Luis de la Cruz-Merino, Rosa Noguera and Tomás Álvaro Naranjo
Biomedicines 2021, 9(7), 798; https://doi.org/10.3390/biomedicines9070798 - 9 Jul 2021
Cited by 9 | Viewed by 4488
Abstract
The study of cancer biology should be based around a comprehensive vision of the entire tumor ecosystem, considering the functional, bioenergetic and metabolic state of tumor cells and those of their microenvironment, and placing particular importance on immune system cells. Enhanced understanding of [...] Read more.
The study of cancer biology should be based around a comprehensive vision of the entire tumor ecosystem, considering the functional, bioenergetic and metabolic state of tumor cells and those of their microenvironment, and placing particular importance on immune system cells. Enhanced understanding of the molecular bases that give rise to alterations of pathways related to tumor development can open up new therapeutic intervention opportunities, such as metabolic regulation applied to immunotherapy. This review outlines the role of various oncometabolites and immunometabolites, such as TCA intermediates, in shaping pro/anti-inflammatory activity of immune cells such as MDSCs, T lymphocytes, TAMs and DCs in cancer. We also discuss the extraordinary plasticity of the immune response and its implication in immunotherapy efficacy, and highlight different therapeutic intervention possibilities based on controlling the balanced systems of specific metabolites with antagonistic functions. Full article
(This article belongs to the Special Issue Immunometabolism and Immunity)
Show Figures

Figure 1

Back to TopTop